Finnish researchers trialed 68 subjects on fortified or non-fortified rye bread for four weeks.
A Finland-based study has brought convincing evidence to the use of functional foods with plant sterols for cholesterol management. Results of the study were published online at the journal Nutrition, Metabolism, and Cardiovascular Diseases.
Researchers at the University of Helsinki assigned 68 subjects to randomized supplementation with plant sterol-enriched rye bread or regular rye bread (control) daily for four weeks. The active rye bread was fortified with 2 g of plant sterols for two weeks, followed by 4 g for the following two weeks. The control bread only received a doubling of fiber content for the second pair of weeks.
Total cholesterol, low-density lipoprotein cholesterol (LDL; also known as “bad” cholesterol), and ratios of total cholesterol to high-density lipoprotein cholesterol (HDL; also known as “good” cholesterol) were measured in each subject.
Patients were monitored for compliance by measurement of a rye fiber-derived biomarker in blood and by being assigned to food diaries.
Two weeks of supplementation with 2 g of plant sterols resulted in reductions of total, LDL, and total-to-HDL ratio by 5.1%, 8.1%, and 7.2%, respectively, compared to placebo. The following two weeks on 4 g of plant sterols provided similar reductions compared to placebo: 6.5%, 10.4%, and 3.7%.
“Rye bread enriched with 2–4 g/d of nonesterified plant sterols beneficially modifies cardiovascular lipid risk factors in normocholesterolemic subjects compared to controls,” concluded the researchers.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.